INDEMNIFICATION AGREEMENTIndemnification Agreement • February 23rd, 2024 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (the “Agreement”), dated as of February 20, 2024, between Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and David J. Arthur (“Indemnitee”).
CONSULTING AGREEMENTConsulting Agreement • February 23rd, 2024 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Consulting Agreement (“Consulting Agreement”) is effective as of February 20, 2024 (the “Effective Date”) by and between Salarius Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and David J. Arthur (“Consultant”), effective generally as of the Effective Date except as otherwise expressly provided below. Consultant and the Company are sometimes referred to herein, individually, as a “Party” or, collectively, as the “Parties.”
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 23rd, 2024 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations
This AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is entered into by and between SALARIUS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and MARK J. ROSENBLUM (the “Executive”), effective as of February 20, 2024 (the “Effective Date”).
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement and General Release • February 23rd, 2024 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations
This Confidential Separation Agreement and General Release (the “Agreement”) is being entered into between DAVID J. ARTHUR (“Executive”) and SALARIUS PHARMACEUTICALS, INC. (the “Company”) as of February 20, 2024 in connection with the termination of Executive’s employment with the Company as of February 20, 2024 (the “Separation Date”). Executive and the Company are referred to collectively as the “Parties.” The Parties executed an Employment Agreement on February 5, 2019 (the “Employment Agreement”), which is incorporated herein by reference and shall apply to this Agreement, along with the September 10, 2019 amendment.
